| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
MRC Brain Metabolism Unit, University Department of Pharmacology, Edinburgh.
1. The effects of adrenalectomy (3 weeks) and dexamethasone (3 h) treatment on the release of corticotrophin-releasing factor-41 (CRF-41), arginine vasopressin (AVP), oxytocin (OT), adrenocorticotrophin (ACTH) and corticosterone were studied in adult female Wistar rats. 2. The animals were anaesthetized with sodium pentobarbitone which, as assessed by the effects on the circadian rhythm of plasma ACTH and corticosterone, appeared to be a better anaesthetic than either urethane or alphaxalone for studies on the hypothalamic-pituitary-adrenal system. 3. Adrenalectomy increased the concentrations of ACTH in peripheral plasma and the output of CRF-41 and AVP into hypophysial portal plasma. 4. Dexamethasone administered to adrenalectomized rats significantly reduced the concentration of ACTH in peripheral plasma and the amount of AVP released into portal plasma. However, dexamethasone did not affect the output of CRF-41 into portal blood. 5. The output of OT into portal plasma was unaffected by either adrenalectomy or dexamethasone treatment. 6. Dexamethasone administered to adrenalectomized rats reduced significantly the ACTH response to CRF-41. 7. These results show that the feed-back action of glucocorticoids is mediated by two mechanisms. The increased release of ACTH which follows adrenolectomy [corrected] is produced predominantly by an increased release of both CRF-41 and AVP into hypophysial portal blood. The intermediate negative feed-back of glucocorticoids is produced by a reduction in the output of AVP but not CRF-41 into portal blood and, as well, by a significant reduction in the responsiveness of the anterior pituitary gland to CRF-41.
This article has been cited by other articles:
|
|
 |
|
  A. Chen, A. Blount, J. Vaughan, B. Brar, and W. Vale Urocortin II Gene Is Highly Expressed in Mouse Skin and Skeletal Muscle Tissues: Localization, Basal Expression in Corticotropin-Releasing Factor Receptor (CRFR) 1- and CRFR2-Null Mice, and Regulation by Glucocorticoids Endocrinology, May 1, 2004; 145(5): 2445 - 2457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chen, J. Vaughan, and W. W. Vale Glucocorticoids Regulate the Expression of the Mouse Urocortin II Gene: A Putative Connection between the Corticotropin-Releasing Factor Receptor Pathways Mol. Endocrinol., August 1, 2003; 17(8): 1622 - 1639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kageyama, C. Li, and W. W. Vale Corticotropin-Releasing Factor Receptor Type 2 Messenger Ribonucleic Acid in Rat Pituitary: Localization and Regulation by Immune Challenge, Restraint Stress, and Glucocorticoids Endocrinology, April 1, 2003; 144(4): 1524 - 1532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Engler, E. Redei, and I. Kola The Corticotropin-Release Inhibitory Factor Hypothesis: A Review of the Evidence for the Existence of Inhibitory as Well as Stimulatory Hypophysiotropic Regulation of Adrenocorticotropin Secretion and Biosynthesis Endocr. Rev., August 1, 1999; 20(4): 460 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Curtis, L. A. Pavcovich, and R. J. Valentino Long-Term Regulation of Locus Ceruleus Sensitivity to Corticotropin-Releasing Factor by Swim Stress J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1211 - 1219. [Abstract] [Full Text]
|
|
|
|
|
|
S. M. Tanimura, G. Sanchez-Watts, and A. G. Watts Peptide Gene Activation, Secretion, and Steroid Feedback during Stimulation of Rat Neuroendocrine Corticotropin-Releasing Hormone Neurons Endocrinology, September 1, 1998; 139(9): 3822 - 3829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. de Kloet, E. Vreugdenhil, M. S. Oitzl, and M. Joëls Brain Corticosteroid Receptor Balance in Health and Disease Endocr. Rev., June 1, 1998; 19(3): 269 - 301. [Abstract] [Full Text]
|
|
|
|
 |
|
 Z. A. Erkut, C. Pool, and D. F. Swaab Glucocorticoids Suppress Corticotropin-Releasing Hormone and Vasopressin Expression in Human Hypothalamic Neurons J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2066 - 2073. [Abstract] [Full Text]
|
|
|
|
|
|
D. A. Giussani, J. A. Winter, S. L. Jenkins, J. D. Tame, L. M. Abrams, X.-Y. Ding, and P. W. Nathanielsz Changes in Fetal Plasma Corticotropin-Releasing Hormone during Androstenedione-Induced Labor in the Rhesus Monkey: Lack of an Effect on the Fetal Hypothalamo-Pituitary-Adrenal Axis Endocrinology, June 1, 1998; 139(6): 2803 - 2810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Sanchez, F. Aguado, F. Sanchez-Toscano, and D. Saphier Neuroendocrine and Immunocytochemical Demonstrations of Decreased Hypothalamo-Pituitary-Adrenal Axis Responsiveness to Restraint Stress after Long-Term Social Isolation Endocrinology, February 1, 1998; 139(2): 579 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hellbach, P. Gärtner, J. Deicke, D. Fischer, A. H. S. Hassan, and O. F. X. Almeida Inherent glucocorticoid response potential of isolated hypothalamic neuroendocrine neurons FASEB J, February 1, 1998; 12(2): 199 - 207. [Abstract] [Full Text]
|
|
|
|
|
|
C. Rabadan-Diehl, G. Makara, A. Kiss, S. Lolait, D. Zelena, T. Ochedalski, and G. Aguilera Regulation of Pituitary V1b Vasopressin Receptor Messenger Ribonucleic Acid by Adrenalectomy and Glucocorticoid Administration Endocrinology, December 1, 1997; 138(12): 5189 - 5194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Larsen, M. Tang-Christensen, and D. S. Jessop Central Administration of Glucagon-Like Peptide-1 Activates Hypothalamic Neuroendocrine Neurons in the Rat Endocrinology, October 1, 1997; 138(10): 4445 - 4455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Pavcovich and R. J. Valentino Regulation of a Putative Neurotransmitter Effect of Corticotropin-Releasing Factor: Effects of Adrenalectomy J. Neurosci., January 1, 1997; 17(1): 401 - 408. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
